BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 2386944)

  • 1. Effect of alpha-interferon, 17 beta-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF 7 cells.
    Bezwoda WR; Meyer K
    Cancer Res; 1990 Sep; 50(17):5387-91. PubMed ID: 2386944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR; Sutherland RL
    Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen.
    Reddel RR; Murphy LC; Sutherland RL
    Cancer Res; 1984 Jun; 44(6):2398-405. PubMed ID: 6722780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC; Katzenellenbogen BS
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.
    Briand P; Lykkesfeldt AE
    Cancer Res; 1984 Mar; 44(3):1114-9. PubMed ID: 6362856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
    Osborne CK; Boldt DH; Estrada P
    Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
    Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
    Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice.
    Brünner N; Bronzert D; Vindeløv LL; Rygaard K; Spang-Thomsen M; Lippman ME
    Cancer Res; 1989 Mar; 49(6):1515-20. PubMed ID: 2924304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7.
    Lykkesfeldt AE; Larsen JK; Christensen IJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S83-90. PubMed ID: 3742066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR; Murphy LC; Hall RE; Sutherland RL
    Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 1 alpha blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro.
    Danforth DN; Sgagias MK
    Cancer Res; 1991 Mar; 51(5):1488-93. PubMed ID: 1997187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
    Benz C; Hollander C; Miller B
    Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cytotoxic drugs on estrogen receptor expression and response to tamoxifen in MCF-7 cells.
    Clarke R; Morwood J; van den Berg HW; Nelson J; Murphy RF
    Cancer Res; 1986 Dec; 46(12 Pt 1):6116-9. PubMed ID: 3779632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor and hormone responsiveness of medullary thyroid carcinoma cells in continuous culture.
    Yang K; Pearson CE; Samaan NA
    Cancer Res; 1988 May; 48(10):2760-3. PubMed ID: 3359436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
    Power KA; Thompson LU
    Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of estrogen receptor and cell proliferation in human breast cancer cells by interferons.
    Sica G; Natoli C; Natoli V; Iacobelli S
    Chemioterapia; 1987 Jun; 6(2 Suppl):692-3. PubMed ID: 3151356
    [No Abstract]   [Full Text] [Related]  

  • 20. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
    Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
    Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.